Please enable JavaScript to continue using this application.

Compare $QTTB vs $STRO | Chartloom

Compare

$QTTB vs $STRO

Q32 Bio Inc · Sutro Biopharma Inc

QTTB

Q32 Bio Inc

STRO

Sutro Biopharma Inc

Compare $QTTB vs $STRO

Comparing Q32 Bio Inc and Sutro Biopharma Inc

QTTBQ32 Bio Inc

STROSutro Biopharma Inc

QTTBQ32 Bio Inc

Market cap

$248M

P/E (TTM)

8.22x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

142.4%

52W performance

178.9%

FCF yield

-8.0%

STROSutro Biopharma Inc

Market cap

$236M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.01x

Rev growth (TTM)

-56.3%

YTD performance

30.2%

52W performance

67.2%

FCF yield

-61.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

QTTB

STRO

Detailed metrics comparison

QTTB

Q32 Bio Inc

STRO

Sutro Biopharma Inc

Market Cap

QTTB$248M

STRO$236M

Enterprise Value

QTTB$142M

STRO$421M

Price

QTTB$8.34

STRO$14.27

P/E Ratio

QTTB8.22x

STRON/A

P/S Ratio

QTTB4.62x

STRO5.17x

EV/Sales

QTTB2.64x

STRO9.22x

EV/EBITDA

QTTB3.69x

STRO0.00x

P/B Ratio

QTTB2.31x

STRO5.78x

P/FCF Ratio

QTTBN/A

STRON/A

EV/FCF

QTTB-7.16x

STRO-2.89x

PEG Ratio

QTTBN/A

STRON/A

Forward P/E (NTM)

QTTBN/A

STRON/A

Forward P/S (NTM)

QTTBN/A

STRO6.01x

Revenue (TTM)

QTTB$54M

STRO$46M

Revenue Growth (YoY)

QTTBN/A

STRO-56.3%

Forward Rev Growth

QTTB215.1%

STRO-19.2%

Gross Margin (TTM)

QTTB0.0%

STRO0.0%

Operating Margin (TTM)

QTTB85.4%

STRO0.0%

EBITDA Margin (TTM)

QTTB71.6%

STRO-275.3%

Net Margin (TTM)

QTTB93.7%

STRO-395.2%

FCF Margin (TTM)

QTTB-36.9%

STRO-318.6%

Net Income (TTM)

QTTB$50M

STRO$-181M

FCF (TTM)

QTTB$-20M

STRO$-146M

EPS (TTM)

QTTB$0.00

STRO-$10.90

ROE (TTM)

QTTB137.4%

STRO-22384.0%

ROA (TTM)

QTTB45.1%

STRO-8812.0%

ROIC (TTM)

QTTB111.6%

STRO-22384.0%

Cash

QTTB$106M

STRO$54M

Debt

QTTB$0

STRO$239M

Net Cash/Debt

QTTB$106M

STRO$-185M

Current Ratio (TTM)

QTTB20.30x

STRO3.32x

Quick Ratio (TTM)

QTTB19.80x

STRO3.22x

Debt/Equity (TTM)

QTTB2.29x

STRO4.05x

Debt/Assets (TTM)

QTTB0.0%

STRO0.0%

Interest Coverage (TTM)

QTTBN/A

STRON/A

Net Debt/EBITDA (TTM)

QTTB0.00x

STRO0.00x

Beta

QTTB0.50

STRO1.47

52W Performance

QTTB178.9%

STRO67.2%

YTD Performance

QTTB142.4%

STRO30.2%

% from 52W High

QTTB-64.6%

STRO-67.5%

% from 52W Low

QTTB337.8%

STRO99.6%

Asset Turnover (TTM)

QTTB0.87x

STRO0.22x

FCF Yield (TTM)

QTTB-8.0%

STRO-61.6%

Earnings Yield (TTM)

QTTB20.3%

STRO-76.4%

Dividend Yield (TTM)

QTTBN/A

STRON/A

Rule of 40

QTTB-36.9

STRO-374.9

EV/GP/RG

QTTBN/A

STRON/A

Ticker research

View QTTB research View STRO research

Metric	QTTB Q32 Bio Inc	STRO Sutro Biopharma Inc
Market & Valuation
Market Cap	$248M	$236M
Enterprise Value	$142M	$421M
Price	$8.34	$14.27
P/E Ratio	8.22x	N/A
P/S Ratio	4.62x	5.17x
EV/Sales	2.64x	9.22x
EV/EBITDA	3.69x	0.00x
P/B Ratio	2.31x	5.78x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.16x	-2.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	6.01x
Revenue & Growth
Revenue (TTM)	$54M	$46M
Revenue Growth (YoY)	N/A	-56.3%
Forward Rev Growth	215.1%	-19.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	85.4%	0.0%
EBITDA Margin (TTM)	71.6%	-275.3%
Net Margin (TTM)	93.7%	-395.2%
FCF Margin (TTM)	-36.9%	-318.6%
Net Income (TTM)	$50M	$-181M
FCF (TTM)	$-20M	$-146M
EPS (TTM)	$0.00	-$10.90
ROE (TTM)	137.4%	-22384.0%
ROA (TTM)	45.1%	-8812.0%
ROIC (TTM)	111.6%	-22384.0%
Financial Health
Cash	$106M	$54M
Debt	$0	$239M
Net Cash/Debt	$106M	$-185M
Current Ratio (TTM)	20.30x	3.32x
Quick Ratio (TTM)	19.80x	3.22x
Debt/Equity (TTM)	2.29x	4.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.50	1.47
52W Performance	178.9%	67.2%
YTD Performance	142.4%	30.2%
% from 52W High	-64.6%	-67.5%
% from 52W Low	337.8%	99.6%
Efficiency & Yields
Asset Turnover (TTM)	0.87x	0.22x
FCF Yield (TTM)	-8.0%	-61.6%
Earnings Yield (TTM)	20.3%	-76.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-36.9	-374.9
EV/GP/RG	N/A	N/A
Ticker research	View QTTB research	View STRO research

Valuation

P/E Ratio

QTTB

8.22x

P/S Ratio

QTTB

4.62x

STRO

5.17x

EV/FCF

QTTB

-7.16x

STRO

-2.89x

Growth & revenue

Revenue Growth TTM

STRO

-56.3%

Forward Revenue Growth

QTTB

215.1%

STRO

-19.2%

Profitability & performance

Gross Margin

QTTB

0.0%

STRO

0.0%

ROE

QTTB

137.4%

STRO

-22384.0%

FCF Yield %

QTTB

-8.0%

STRO

-61.6%

52-Week Performance

QTTB

178.9%

STRO

67.2%

Detailed metrics comparison

QTTB

Q32 Bio Inc

STRO

Sutro Biopharma Inc

Market Cap

QTTB$248M

STRO$236M

Enterprise Value

QTTB$142M

STRO$421M

Price

QTTB$8.34

STRO$14.27

P/E Ratio

QTTB8.22x

STRON/A

P/S Ratio

QTTB4.62x

STRO5.17x

EV/Sales

QTTB2.64x

STRO9.22x

EV/EBITDA

QTTB3.69x

STRO0.00x

P/B Ratio

QTTB2.31x

STRO5.78x

P/FCF Ratio

QTTBN/A

STRON/A

EV/FCF

QTTB-7.16x

STRO-2.89x

PEG Ratio

QTTBN/A

STRON/A

Forward P/E (NTM)

QTTBN/A

STRON/A

Forward P/S (NTM)

QTTBN/A

STRO6.01x

Revenue (TTM)

QTTB$54M

STRO$46M

Revenue Growth (YoY)

QTTBN/A

STRO-56.3%

Forward Rev Growth

QTTB215.1%

STRO-19.2%

Gross Margin (TTM)

QTTB0.0%

STRO0.0%

Operating Margin (TTM)

QTTB85.4%

STRO0.0%

EBITDA Margin (TTM)

QTTB71.6%

STRO-275.3%

Net Margin (TTM)

QTTB93.7%

STRO-395.2%

FCF Margin (TTM)

QTTB-36.9%

STRO-318.6%

Net Income (TTM)

QTTB$50M

STRO$-181M

FCF (TTM)

QTTB$-20M

STRO$-146M

EPS (TTM)

QTTB$0.00

STRO-$10.90

ROE (TTM)

QTTB137.4%

STRO-22384.0%

ROA (TTM)

QTTB45.1%

STRO-8812.0%

ROIC (TTM)

QTTB111.6%

STRO-22384.0%

Cash

QTTB$106M

STRO$54M

Debt

QTTB$0

STRO$239M

Net Cash/Debt

QTTB$106M

STRO$-185M

Current Ratio (TTM)

QTTB20.30x

STRO3.32x

Quick Ratio (TTM)

QTTB19.80x

STRO3.22x

Debt/Equity (TTM)

QTTB2.29x

STRO4.05x

Debt/Assets (TTM)

QTTB0.0%

STRO0.0%

Interest Coverage (TTM)

QTTBN/A

STRON/A

Net Debt/EBITDA (TTM)

QTTB0.00x

STRO0.00x

Beta

QTTB0.50

STRO1.47

52W Performance

QTTB178.9%

STRO67.2%

YTD Performance

QTTB142.4%

STRO30.2%

% from 52W High

QTTB-64.6%

STRO-67.5%

% from 52W Low

QTTB337.8%

STRO99.6%

Asset Turnover (TTM)

QTTB0.87x

STRO0.22x

FCF Yield (TTM)

QTTB-8.0%

STRO-61.6%

Earnings Yield (TTM)

QTTB20.3%

STRO-76.4%

Dividend Yield (TTM)

QTTBN/A

STRON/A

Rule of 40

QTTB-36.9

STRO-374.9

EV/GP/RG

QTTBN/A

STRON/A

Ticker research

View QTTB research View STRO research

Metric	QTTB Q32 Bio Inc	STRO Sutro Biopharma Inc
Market & Valuation
Market Cap	$248M	$236M
Enterprise Value	$142M	$421M
Price	$8.34	$14.27
P/E Ratio	8.22x	N/A
P/S Ratio	4.62x	5.17x
EV/Sales	2.64x	9.22x
EV/EBITDA	3.69x	0.00x
P/B Ratio	2.31x	5.78x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.16x	-2.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	6.01x
Revenue & Growth
Revenue (TTM)	$54M	$46M
Revenue Growth (YoY)	N/A	-56.3%
Forward Rev Growth	215.1%	-19.2%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	85.4%	0.0%
EBITDA Margin (TTM)	71.6%	-275.3%
Net Margin (TTM)	93.7%	-395.2%
FCF Margin (TTM)	-36.9%	-318.6%
Net Income (TTM)	$50M	$-181M
FCF (TTM)	$-20M	$-146M
EPS (TTM)	$0.00	-$10.90
ROE (TTM)	137.4%	-22384.0%
ROA (TTM)	45.1%	-8812.0%
ROIC (TTM)	111.6%	-22384.0%
Financial Health
Cash	$106M	$54M
Debt	$0	$239M
Net Cash/Debt	$106M	$-185M
Current Ratio (TTM)	20.30x	3.32x
Quick Ratio (TTM)	19.80x	3.22x
Debt/Equity (TTM)	2.29x	4.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.50	1.47
52W Performance	178.9%	67.2%
YTD Performance	142.4%	30.2%
% from 52W High	-64.6%	-67.5%
% from 52W Low	337.8%	99.6%
Efficiency & Yields
Asset Turnover (TTM)	0.87x	0.22x
FCF Yield (TTM)	-8.0%	-61.6%
Earnings Yield (TTM)	20.3%	-76.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-36.9	-374.9
EV/GP/RG	N/A	N/A
Ticker research	View QTTB research	View STRO research